A detailed history of Vestmark Advisory Solutions, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 620,707 shares of PACB stock, worth $1.41 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
620,707
Previous 710,850 12.68%
Holding current value
$1.41 Million
Previous $973,000 8.43%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.2 - $2.17 $108,171 - $195,610
-90,143 Reduced 12.68%
620,707 $1.06 Million
Q2 2024

Aug 12, 2024

SELL
$1.36 - $3.65 $305,237 - $819,202
-224,439 Reduced 24.0%
710,850 $973,000
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $1.55 Million - $4.22 Million
440,499 Added 89.03%
935,289 $3.51 Million
Q4 2023

Feb 06, 2024

BUY
$5.97 - $10.36 $2.95 Million - $5.13 Million
494,790 New
494,790 $4.85 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $510M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Vestmark Advisory Solutions, Inc. Portfolio

Follow Vestmark Advisory Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.